Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas

This study has suspended participant recruitment.
Sponsor:
Collaborator:
Johns Hopkins University
Information provided by (Responsible Party):
Ludwig Institute for Cancer Research
ClinicalTrials.gov Identifier:
NCT01490047
First received: December 8, 2011
Last updated: April 16, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)